newsfilter
← Latest News
Earnings Call Transcripts·

Silence Therapeutics Webcast to Discuss Topline Results from Phase 2 SANRECO Study of Divesiran - SILENCE THERAPEUTICS PLC

Thanks everyone for joining us. With me today are Ian Ross, our Chairman and Interim Principal Executive Officer, who will provide some opening comments, and Steve Romano, our Chief R&D Officer, who will review the San R

Company
SILENCE THERAPEUTICS PLC
Keywords
SILENCE THERAPEUTICS PLC